Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States (Unbekannt)
Freier Zugriff
- Neue Suche nach: Yang, Xiaoqin
- Neue Suche nach: Laliberté, François
- Neue Suche nach: Germain, Guillaume
- Neue Suche nach: Raut, Monika
- Neue Suche nach: Duh, Mei Sheng
- Neue Suche nach: Sen, Shuvayu S.
- Neue Suche nach: Lejeune, Dominique
- Neue Suche nach: Desai, Kaushal
- Neue Suche nach: Armand, Philippe
- Neue Suche nach: Yang, Xiaoqin
- Neue Suche nach: Laliberté, François
- Neue Suche nach: Germain, Guillaume
- Neue Suche nach: Raut, Monika
- Neue Suche nach: Duh, Mei Sheng
- Neue Suche nach: Sen, Shuvayu S.
- Neue Suche nach: Lejeune, Dominique
- Neue Suche nach: Desai, Kaushal
- Neue Suche nach: Armand, Philippe
In:
Journal of Medical Economics
;
24
, 1
;
469-478
;
2021
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States
-
Beteiligte:Yang, Xiaoqin ( Autor:in ) / Laliberté, François ( Autor:in ) / Germain, Guillaume ( Autor:in ) / Raut, Monika ( Autor:in ) / Duh, Mei Sheng ( Autor:in ) / Sen, Shuvayu S. ( Autor:in ) / Lejeune, Dominique ( Autor:in ) / Desai, Kaushal ( Autor:in ) / Armand, Philippe ( Autor:in )
-
Erschienen in:Journal of Medical Economics ; 24, 1 ; 469-478
-
Verlag:
- Neue Suche nach: Taylor & Francis
-
Erscheinungsdatum:01.01.2021
-
Format / Umfang:10 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Unbekannt
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 24, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Healthcare resource utilization and exacerbations in patients with chronic obstructive pulmonary disease treated with nebulized glycopyrrolate in the USA: a real-world data analysisNiu, Xiaoli / Divino, Victoria / Sharma, Sanjay / Dekoven, Mitch / Anupindi, Vamshi Ruthwik / Dembek, Carole et al. | 2021
- 10
-
Healthcare resource utilization and costs for hip dislocation following primary total hip arthroplasty in the medicare populationMantel, Jack / Chitnis, Abhishek S. / Ruppenkamp, Jill / Holy, Chantal E. / Daccach, Juan et al. | 2021
- 19
-
A budget impact analysis of gilteritinib for the treatment of relapsed or refractory FLT3 mut+ acute myeloid leukemia in a US health planPandya, Bhavik J. / Yang, Hongbo / Schmeichel, Cynthia / Qi, Cynthia Z. / Shah, Manasee V. et al. | 2021
- 29
-
Cost-effectiveness of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosisBloudek, Lisa M. / Gillard, Kristin Khalaf / Nguyen, Victor B. / Klein, Stephanie Zone et al. | 2021
- 38
-
Evaluation of access to care issues in patients with breast cancerBrown, Carolyn M. / Richards, Kristin M. / Vohra, Yogesh / Kanu, Chisom / Stevens, Laura / Sasane, Rahul / Balu, Sanjeev / McAneny, Barbara et al. | 2021
- 46
-
Identifying disability level in multiple sclerosis patients in a U.S.-based health plan claims databaseBerkovich, Regina / Fox, Edward / Okai, Annette / Ding, Yao / Gorritz, Magdaliz / Bartolome, Lauren / Wade, Rolin L. / Su, Wendy / Johnson, Kristen M. / Russo, Patricia et al. | 2021
- 54
-
Effect of direct oral feeding following minimally invasive esophagectomy on costs and quality of lifePattamatta, Madhuri / Fransen, Laura F. C. / Dolmans-Zwartjes, Annemarie C. P. / Nieuwenhuijzen, Grard A. P. / Evers, Silvia M. A. A. / Kouwenhoven, Ewout A. / van Det, Marc J. / Hiligsmann, Mickael / Luyer, Misha D. P. et al. | 2021
- 61
-
Economic modeling of reSET-O, a prescription digital therapeutic for patients with opioid use disorderWang, Weijia / Gellings Lowe, Nicole / Jalali, Ali / Murphy, Sean M. et al. | 2021
- 69
-
The health economic impact of varying levels of adherence to colorectal screening on providers and payersHathway, Joanne M. / Miller-Wilson, Lesley-Ann / Yao, Weiyu / Jensen, Ivar S. / Weinstein, Milton C. / Parks, Philip D. et al. | 2021
- 79
-
A comparison of mixture cure fraction models to traditional parametric survival models in estimation of the cost-effectiveness of nivolumab for relapsed small cell lung cancerRoth, Joshua A. / Yuan, Yong / Othus, Megan / Danese, Mark / Wagner, Samuel / Penrod, John R. / Ramsey, Scott D. et al. | 2021
- 87
-
Long-term cost-effectiveness of a disease management program for patients with atrial fibrillation compared to standard care – a multi-state survival model based on a randomized controlled trialGao, Lan / Scuffham, Paul / Ball, Jocasta / Stewart, Simon / Byrnes, Joshua et al. | 2021
- 96
-
Benefits of fracture liaison services (FLS) in four Latin American countries: Brazil, Mexico, Colombia, and ArgentinaAziziyeh, Rima / Perlaza, Javier Garcia / Saleem, Najma / Guiang, Hannah / Szafranski, Kirk / McTavish, Rebecca K. et al. | 2021
- 103
-
Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesiaGanz, Michael L. / Chavan, Ameya / Dhanda, Rahul / Serbin, Michael / Yonan, Charles et al. | 2021
- 114
-
Healthcare resource utilization and costs among patients with relapsed and/or refractory multiple myeloma treated with proteasome inhibitors in real-world clinical practice in GermanySteinmetz, Tilman Hans / Singh, Moushmi / Lebioda, Andrea / Fink, Leah / Schoehl, Martina / Rieth, Achim / Gonzalez-McQuire, Sebastian / Engelhardt, Monika et al. | 2021
- 123
-
Estimating the public economic consequences of cardiovascular disease-attributable events and evolocumab treatment in AustraliaKotsopoulos, Nikolaos / Connolly, Mark P. / Li, Jinjing et al. | 2021
- 131
-
Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United StatesCai, Beilei / Zhou, Zheng-Yi / Xue, Weiguang / Hazra, Nisha C. / Singh, Mukesh / Mishra, Dinesh / Brixner, Diana / Oderda, Gary / Biskupiak, Joseph et al. | 2021
- 140
-
Societal costs of primary progressive multiple sclerosis in Australia and the economic impact of a hypothetical disease-modifying treatment that could delay disease progressionBrown, Laurie J. / Li, Jinjing / Brunner, Matthias / Snoke, Martin / La, Hai A. et al. | 2021
- 150
-
The cost-effectiveness of glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed acute myeloid leukemia in adult patients who are not eligible to receive intensive induction chemotherapy in CanadaHu, Yannan / Charaan, Majed / van Oostrum, Ilse / Heeg, Bart / Bell, Timothy et al. | 2021
- 162
-
Willingness to pay for primary health care at public facilities in the Western Cape Province, Cape Town, South AfricaChiwire, P. / Evers, S. M. / Mahomed, H. / Hiligsmann, M. et al. | 2021
- 173
-
Comparison of cost-effectiveness of implantable cardioverter defibrillator therapy in patients for primary prevention in Latin America: an analysis using the Improve SCA studyHiguera, Lucas / Holbrook, Reece / Wherry, Kael / Rodriguez, Diego A. / Cuesta, Alejandro / Valencia, Juan / Arcos, Julián / López Gómez, Agustín et al. | 2021
- 181
-
Humanistic burden among caregivers of patients with Alzheimer’s disease or dementia in Japan: a large-scale cross-sectional surveyOhno, Shinya / Chen, Yirong / Sakamaki, Hiroyuki / Matsumaru, Naoki / Yoshino, Motoaki / Tsukamoto, Katsura et al. | 2021
- 193
-
Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stageGagnon-Sanschagrin, Patrick / Liang, Yawen / Sanon, Myrlene / Oberdhan, Dorothee / Guérin, Annie / Cloutier, Martin et al. | 2021
- 202
-
Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United StatesVolk, Michael L. / Burne, Rebecca / Guérin, Annie / Shi, Sherry / Joseph, George J. / Heimanson, Zeev / Ahmad, Maliha et al. | 2021
- 212
-
Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarinMilentijevic, Dejan / Lin, Jennifer H. / Chen, Yen-Wen / Kogan, Emily / Shrivastava, Shubham / Sjoeland, Erik / Alberts, Mark et al. | 2021
- 218
-
Budget impact analysis of Jivi (damoctocog alfa pegol, Bay 94-9027) in severe hemophilia A in JapanFujii, Teruhisa / Kidoguchi, Yuko / Takahashi, Noriko / Yu, Eric / Ainiwaer, Dilinuer / Byrne, Aidan et al. | 2021
- 226
-
Estimating the preferences and willingness-to-pay for colorectal cancer screening: an opportunity to incorporate the perspective of population at risk into policy development in ThailandPhisalprapa, Pochamana / Ngorsuraches, Surachat / Wanishayakorn, Tanatape / Kositamongkol, Chayanis / Supakankunti, Siripen / Chaiyakunapruk, Nathorn et al. | 2021
- 234
-
Healthcare resource utilization and costs in patients with myelodysplastic syndromes treated with hypomethylating agents: a SEER-Medicare analysisStein, Eytan M. / Bonifacio, Gaetano / Latrémouille-Viau, Dominick / Shi, Sherry / Guérin, Annie / Wu, Eric Q. / Sadek, Islam / Cao, Xiting et al. | 2021
- 244
-
Estimation of the value of convenience in taking influenza antivirals in Japanese adult patients between baloxavir marboxil and neuraminidase inhibitors using a conjoint analysisHosogaya, Naoki / Takazono, Takahiro / Yokomasu, Akira / Hiroi, Shinzo / Ikeoka, Hidetoshi / Iwasaki, Kosuke / Takeshima, Tomomi / Mukae, Hiroshi et al. | 2021
- 255
-
Incidence, predictors, and economic burden of circular anastomotic complications in left-sided colorectal reconstructions involving manual circular staplersFortin, Stephen P. / Johnston, Stephen S. / Chaudhuri, Rusha / Fryrear, RaymondII / Roy, Sanjoy et al. | 2021
- 266
-
Burden of caring for Alzheimer’s disease or dementia patients in Japan, the US, and EU: results from the National Health and Wellness Survey: a cross-sectional surveyOhno, Shinya / Chen, Yirong / Sakamaki, Hiroyuki / Matsumaru, Naoki / Yoshino, Motoaki / Tsukamoto, Katsura et al. | 2021
- 279
-
Cost-effectiveness of tofacitinib compared with infliximab, adalimumab, golimumab, vedolizumab and ustekinumab for the treatment of moderate to severe ulcerative colitis in GermanySardesai, Aditya / Dignass, Axel / Quon, Peter / Milev, Sandra / Cappelleri, Joseph C. / Kisser, Agnes / Modesto, Irene / Sharma, Puza P. et al. | 2021
- 291
-
Pembrolizumab plus axitinib and nivolumab plus ipilimumab as first-line treatments of advanced intermediate- or poor-risk renal-cell carcinoma: a number needed to treat analysis from the Brazilian private perspectiveEngel Ayer Botrel, Tobias / Datz Abadi, Márcia / Chabrol Haas, Laura / da Veiga, Cássia Rita Pereira / de Vasconcelos Ferreira, Dominihemberg / Jardim, Denis Leonardo et al. | 2021
- 299
-
Risk and cost of infection-related hospitalizations in medicare beneficiaries with comorbid rheumatoid arthritis treated with abatacept versus other targeted disease-modifying anti-rheumatic drugsPatel, Vardhaman / Pulungan, Zulkarnain / Shah, Anne / Kambhampati, Mahesh / Lobo, Francis / Petrilla, Allison et al. | 2021
- 308
-
Health outcomes and economic burden of hospitalized COVID-19 patients in the United StatesDi Fusco, Manuela / Shea, Kimberly M. / Lin, Jay / Nguyen, Jennifer L. / Angulo, Frederick J. / Benigno, Michael / Malhotra, Deepa / Emir, Birol / Sung, Anita H. / Hammond, Jennifer L. et al. | 2021
- 318
-
Modeling the economic value of Ceribell Rapid Response EEG in the inpatient hospital settingNey, John P. / Gururangan, Kapil / Parvizi, Josef et al. | 2021
- 328
-
Real-world impact of brain metastases on healthcare utilization and costs in patients with non-small cell lung cancer treated with EGFR-TKIs in the USKong, Amanda M. / Pavilack, Melissa / Huo, Hairong / Shenolikar, Rahul / Moynihan, Meghan / Marchlewicz, Elizabeth H. / Chebili-Larson, Christina / Min, Stella / Subramaniam, Deepa S. et al. | 2021
- 339
-
Cost-effectiveness analysis of fruquintinib versus regorafenib as the third-line therapy for metastatic colorectal cancer in ChinaGuan, Xin / Li, Hongchao / Xiong, Xiaomo / Peng, Cike / Wang, Ning / Ma, Xiao / Ma, Aixia et al. | 2021
- 345
-
Influence of neurovascular embolic coil primary wind diameter on aneurysm packing density and case costsGrandhi, Ramesh / Kottenmeier, Emilie / Cameron, Heather L. / Kane, Sarah T. / Taussky, Philipp et al. | 2021
- 352
-
Healthcare resource utilization, costs and treatment patterns in patients with bipolar disorder treated with lurasidone or cariprazineHuang, Huan / Schmerold, Luke / Dembek, Carole / Fan, Qi / Dieyi, Christopher / Williams, G. Rhys / Loebel, Antony et al. | 2021
- 363
-
Adult lifetime cost of hemophilia B management in the US: payer and societal perspectives from a decision analytic modelLi, Nanxin / Sawyer, Eileen K. / Maruszczyk, Konrad / Guzauskas, Greg / Slomka, Marta T. / Burke, Tom / Martin, Antony P. / O’Hara, Jamie / Stevenson, Matt / Recht, Michael et al. | 2021
- 373
-
A pragmatic methodology for the evaluation of digital care management in the context of multimorbidityLindemer, Emily / Jouni, Mohammad / Nikolaev, Nikolay / Reidy, Pat / Mattie, Heather / Rogers, Jameson K. / Giangreco, LouAnne / Sherman, Michael / Bartels, Matthew / Panch, Trishan et al. | 2021
- 386
-
Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costsWallick, Chris / Wu, Ning / To, Tu My / Keebler, Daniel / Moawad, Dalia et al. | 2021
- 394
-
Standard table direct anterior approach within an early discharge protocol for cementless total hip arthroplasty: experience from a Japanese hospitalNakakita, Yoshiatsu / Bourcet, Anh / Mantel, Jack / Park, HyeJin / Rossi, Anne / Oinuma, Kazuhiro / Shiratsuchi, Hideaki et al. | 2021
- 402
-
Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularizationDesai, Urvi / Kharat, Akshay / Hess, Connie N. / Milentijevic, Dejan / Laliberté, François / Zuckerman, Peter / Benson, John / Lefebvre, Patrick / Hiatt, William R. / Bonaca, Marc P. et al. | 2021
- 410
-
Corneal cross-linking versus conventional management for keratoconus: a lifetime economic modelLindstrom, Richard L. / Berdahl, John P. / Donnenfeld, Eric D. / Thompson, Vance / Kratochvil, David / Wong, Chiang / Falvey, Heather / Lytle, Grace / Botteman, Marc F. / Carter, John A. et al. | 2021
- 421
-
Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United StatesSimons, Claire L. / Malone, Daniel / Wang, Michael / Maglinte, Gregory A. / Inocencio, Tim / Wade, Sally W. / Bennison, Craig / Shah, Bijal et al. | 2021
- 432
-
Burden of acromegaly in the United States: increased health services utilization, location of care, and costs of careRibeiro-Oliveira, AntonioJr / Brook, Richard A. / Munoz, Kathryn A. / Beren, Ian A. / Whalen, John D. / Kleinman, Nathan L. / Yuen, Kevin C. J. et al. | 2021
- 440
-
The direct and indirect economic burden of hypothyroidism in the United States: a retrospective claims database studyHepp, Zsolt / Lage, Maureen J. / Espaillat, Ramon / Gossain, Ved V. et al. | 2021
- 447
-
The cost-effectiveness of dacomitinib in first-line treatment of advanced/metastatic epidermal growth factor receptor mutation-positive non-small-cell lung cancer (EGFRm NSCLC) in SwedenNilsson, Fredrik O. L. / Gal, Peter / Houisse, Ivan / Ivanova, Jasmina I. / Asanin, Sandra T. et al. | 2021
- 458
-
Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United StatesLiu, Rongzhe / Oluwole, Olalekan O. / Diakite, Ibrahim / Botteman, Marc F. / Snider, Julia Thornton / Locke, Frederick L. et al. | 2021
- 469
-
Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United StatesYang, Xiaoqin / Laliberté, François / Germain, Guillaume / Raut, Monika / Duh, Mei Sheng / Sen, Shuvayu S. / Lejeune, Dominique / Desai, Kaushal / Armand, Philippe et al. | 2021
- 479
-
The implications of suboptimal year-1 outcomes with disease-modifying therapy in employees with multiple sclerosisHersh, Carrie M. / Brook, Richard A. / Beren, Ian A. / Rohrbacker, Nicholas J. / Lebson, Lori / Henke, Christian / Phillips, Amy L. et al. | 2021
- 487
-
Budget impact analysis: can we afford the added value?Petrou, Panagiotis et al. | 2021
- 490
-
Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in GermanyCai, Rui / Gerlier, Laetitia / Eichner, Martin / Schwehm, Markus / Rajaram, Sankarasubramanian / Mould-Quevedo, Joaquin / Lamotte, Mark et al. | 2021
- 502
-
Setting and maintaining standards for patient-reported outcome measures: can we rely on the COSMIN checklists?McKenna, Stephen P. / Heaney, Alice et al. | 2021
- 512
-
Novel acute therapies in the treatment of migraine: impact of re-dosing on cost–utility outcomesJohnston, Karissa M. / L'italien, Gilbert / Harris, Linda / Deighton, Alison / Popoff, Evan / Croop, Robert / Coric, Vladimir et al. | 2021
- 514
-
Impact of an active hemostatic product treatment approach on bleeding-related complications and hospital costs among inpatient surgeries in the United StatesIannitti, David A. / Kim, Chong / Ito, Diane / Epstein, Josh et al. | 2021
- 524
-
A device category economic model of electrosurgery technologies across procedure types: a U.S. hospital budget impact analysisFerko, Nicole / Wright, George W. J. / Syed, Imran / Naoumtchik, Elena / Tommaselli, Giovanni A. / Gangoli, Gaurav et al. | 2021
- 536
-
Is there a correlation between total fertility rate, utilization of assisted reproduction technology, and national wealth in Europe?Lass, Amir / Lass, Geffen et al. | 2021
- 540
-
Real-world assessment of “OFF” episode–related healthcare resource utilization among patients with Parkinson’s disease in the United StatesThach, Andrew / Jones, Eddie / Pappert, Eric / Pike, James / Wright, Jack / Gillespie, Alexander et al. | 2021
- 550
-
Healthcare resource utilization and costs of rivaroxaban versus warfarin among non-valvular atrial fibrillation (NVAF) patients with obesity in a US populationBerger, Jeffrey S. / Laliberté, François / Kharat, Akshay / Lejeune, Dominique / Moore, Kenneth Todd / Jung, Young / Lefebvre, Patrick / Ashton, Veronica et al. | 2021
- 563
-
Cost-effectiveness of opicapone and entacapone in reducing OFF-time in Parkinson’s disease patients treated with levodopa/carbidopaHansen, Ryan N. / Suh, Kangho / Serbin, Michael / Yonan, Chuck / Sullivan, Sean D. et al. | 2021
- 570
-
Two-year PAD-related health care costs in patients undergoing lower extremity endovascular revascularization: results from the LIBERTY 360° trialMagnuson, Elizabeth A. / Li, Haiyan / Vilain, Katherine / Armstrong, Ehrin J. / Secemsky, Eric A. / Giannopoulos, Stefanos / Adams, George L. / Mustapha, Jihad / Cohen, David J. et al. | 2021
- 581
-
Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims databaseExuzides, Alex / Wu, Ning / Sheinson, Daniel / Flores Avile, Carlos / Costantino, Cristina / Sidiropoulos, Paris et al. | 2021
- 589
-
Real-world data analysis of the clinical and economic burden and risk factors in patients with major depressive disorder with an inadequate response to initial antidepressantsPark, HyeJin / Park, Chan Mi / Woo, Jong-Min / Shin, Ju-Young / Lee, Eui-Kyung / Kwon, Sun-Hong et al. | 2021
- 598
-
Conversion from pegfilgrastim with on-body injector to pegfilgrastim-jmdb: cost-efficiency analysis and budget-neutral expanded access to prophylaxis and treatmentMcBride, Ali / MacDonald, Karen / Fuentes-Alburo, Adolfo / Abraham, Ivo et al. | 2021
- 607
-
Cost-effectiveness of nivolumab in squamous and non-squamous non-small cell lung cancer in Canada and Sweden: an update with 5-year dataChaudhary, Mohammad A. / Holmberg, Christoffer / Lakhdari, Khalid / Smare, Caitlin / Theriou, Chloi / Dale, Peter / Penrod, John R. et al. | 2021
- 620
-
Cost burden of post-transplant lymphoproliferative disease following kidney transplants in Medicare-eligible patients by survival statusHart, Allyson / Ahn, Yoon Son / Watson, Crystal / Skeans, Melissa / Barlev, Arie / Thompson, Bryn / Dharnidharka, Vikas R. et al. | 2021
- 628
-
Cost-effectiveness analysis of defibrotide in the treatment of patients with severe veno-occlusive disease/sinusoidal obstructive syndrome with multiorgan dysfunction following hematopoietic cell transplantation in SpainCarcedo Rodriguez, David / Artola Urain, Teresa / Chinea Rodriguez, Anabelle / García Torres, Estefanía / González Vicent, Marta / Gutiérrez García, Gonzalo / Regueiro García, Alexandra / Calvo Hidalgo, Marcos / Villacampa, Alba et al. | 2021
- 637
-
Cost-effectiveness and budget impact analyses of tisagenlecleucel in adult patients with relapsed or refractory diffuse large B-cell lymphoma from Singapore’s private insurance payer’s perspectiveWang, Xiao Jun / Wang, Yi-Ho / Li, Shing Chau Tony / Gkitzia, Christina / Lim, Soon Thye / Koh, Liang Piu / Lim, Francesca Lorraine Wei Inng / Hwang, William Ying Khee et al. | 2021
- 654
-
Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare populationFisher, Deborah A. / Karlitz, Jordan J. / Jeyakumar, Sushanth / Smith, Nathaniel / Limburg, Paul / Lieberman, David / Fendrick, A. Mark et al. | 2021
- 665
-
Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world dataYang, Jingyan / Liu, Rongzhe / Granghaud, Anna / Zaidi, Omer / Stephens, Jennifer et al. | 2021
- 675
-
Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancerThurgar, Elizabeth / Gouldson, Mark / Matthijsse, Suzette / Amonkar, Mayur / Marinello, Patricia / Upadhyay, Navneet / Nwankwo, Chizoba / Aguiar-Ibáñez, Raquel et al. | 2021
- 689
-
Continuity and change in the drug supply chain: actors, actions, and aversionsMendoza, Roger Lee et al. | 2021
- 698
-
Quality outcomes, healthcare resource utilization and costs in Medicare patients with chronic heart failure with reduced ejection fraction with and without a worsening eventMentz, Robert J. / Pulungan, Zulkarnain / Kim, Seung / Yang, Mei / Teigland, Christie / Hilkert, Robert / Djatche, Laurence M. et al. | 2021
- 706
-
Burden of illness among Medicare and non-Medicare US populations with acquired thrombotic thrombocytopenic purpuraPollissard, Laurence / Shah, Anne / Punekar, Rajeshwari S. / Petrilla, Allison / Pham, Huy P. et al. | 2021
- 717
-
Healthcare resource use and indirect costs associated with migraine in Italy: results from the My Migraine Voice surveyMartelletti, Paolo / Schwedt, Todd J. / Vo, Pamela / Ritrovato, Daniela / Reilly, Margaret C. / Naclerio, Mariantonietta / Ranjan, Pallavi / Kleebach, Joern / Joshi, Parth et al. | 2021
- 727
-
Cost-effectiveness of defibrotide for treatment of severe veno-occlusive disease: it is time for evidence based economic evaluationsGratwohl, Alois et al. | 2021
- 730
-
Economic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM)Rosli, Mohd Rozaini / Wu, David Bin-Chia / Neoh, Chin Fen / Karuppannan, Mahmathi et al. | 2021
- 741
-
The tyranny of the SW quadrantPetrou, Panagiotis et al. | 2021
- 743
-
Cost-efficiency and expanded access modeling of conversion to biosimilar trastuzumab-dkst with or without pertuzumab in metastatic breast cancerMcBride, Ali / MacDonald, Karen / Fuentes-Alburo, Adolfo / Abraham, Ivo et al. | 2021
- 757
-
Criteria for oral appliance and/or supine avoidance therapy selection based on outcome optimization and cost-effectivenessLevendowski, Daniel J. / Olmstead, Richard / Sall, Edward / Westbrook, Philip R. / Beine, Bretton / Munafo, Dominic et al. | 2021
- 764
-
Modelling the value of innovative treatments for Alzheimer’s disease in the United StatesMakin, Charles / Neumann, Peter / Peschin, Sue / Goldman, Dana et al. | 2021
- 770
-
Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in SwedenAcosta, Carlos / Gianinazzi, Mattia / Dort, Thibaut / Armstrong, Nigel / Ryder, Steve / Lundqvist, Thomas / Ekelund, Mats / Lycke, Jan et al. | 2021
- 781
-
Correction| 2021
- 782
-
Dose escalation and associated costs in biologic treatment of psoriasis based on real-world dataBagel, Jerry / Glick, Brad / Wu, Jashin J. / Chopra, Ishveen / Song, Xue / Brouillette, Matthew / Mendelsohn, Alan / Rozzo, Stephen / Han, George et al. | 2021
- 792
-
Cost-effectiveness of pembrolizumab + chemotherapy versus chemotherapy and pembrolizumab monotherapy in first line treatment of NSCLC in the US – updated analyses with additional trial follow-upInsinga, Ralph P. / Feliciano, Josephine L. / Qiao, Nan / Vandormael, Kristel / Zhang, Ying et al. | 2021
- 806
-
Comparison of healthcare resource utilization and costs of patients with HR+/HER2- advanced breast cancer treated with ribociclib versus other CDK4/6 inhibitorsBurne, Rebecca / Balu, Sanjeev / Guérin, Annie / Bungay, Rebecca / Sin, Roxana / Paul, Mary Lisha et al. | 2021
- 816
-
Budget impact of tepotinib in the treatment of adult patients with metastatic non-small cell lung cancer harboring METex14 skipping alterations in the United StatesStargardter, Matthew / McBride, Ali / Tosh, Jon / Sachdev, Rameet / Yang, Mo / Ambavane, Apoorva / Mittal, Madhav / Vioix, Helene / Liu, Frank Xiaoqing et al. | 2021
- 828
-
The impact of seven major noncommunicable diseases on direct medical costs, absenteeism, and presenteeism in Gulf Cooperation Council countriesFinkelstein, Eric Andrew / Malkin, Jesse D. / Baid, Drishti / Alqunaibet, Ada / Mahdi, Khaled / Al-Thani, Mohammed Bin Hamad / Abdulla Bin Belaila, Buthaina / Al Nawakhtha, Ebrahim / Alqahtani, Saleh / El-Saharty, Sameh et al. | 2021
- 835
-
Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103–113Xue, Weiguang / Ribalov, Rinat / Zhou, Zheng-Yi / Ayyagari, Rajeev / Leo, Sam et al. | 2021
- 837
-
The improved survival rate and cost-effectiveness of a 7-day continuous subcutaneous insulin infusion setKwa, Timothy / Zhang, Gina / Shepard, Katie / Wherry, Kael / Chattaraj, Sarnath et al. | 2021
- 846
-
The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best–worst scaling approachWranik, Wiesława Dominika / Székely, Ronaldo-Raul / Mayer, Susanne / Hiligsmann, Mickaël / Cheung, Kei Long et al. | 2021
- 857
-
Reply to the concerns raised by McKenna and Heaney about COSMINMokkink, Lidwine B. / Terwee, Caroline B. / de Vet, Henrica C. W / Bouter, Lex M. / Alonso, Jordi / Patrick, D. et al. | 2021
- 860
-
COSMIN reviews: the need to consider measurement theory, modern measurement and a prospective rather than retrospective approach to evaluating patient-based measuresMcKenna, Stephen P. / Heaney, Alice et al. | 2021
- 862
-
Re: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691–697Kiri, Victor / MacKenzie, Gilbert et al. | 2021
- 864
-
Reply: Re: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691–697Harris, Linda / Graham, Sophie / MacLachlan, Sharon / Exuzides, Alex / Jacob, Saiju et al. | 2021
- 866
-
Healthcare costs of patients with cancer stratified by Khorana score risk levelsKhorana, Alok A. / Kuderer, Nicole M. / McCrae, Keith / Milentijevic, Dejan / Germain, Guillaume / Laliberté, François / MacKnight, Sean D. / Lefebvre, Patrick / Lyman, Gary H. / Streiff, Michael B. et al. | 2021
- 874
-
Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in SpainGonzález-Barcala, Francisco Javier / Muñoz-Gall, Xavier / Mariscal, Esther / García, Andrea / Yang, Shibing / van de Wetering, Gijs / Izquierdo-Alonso, José Luis et al. | 2021
- 883
-
Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UKRoze, Stéphane / Buompensiere, Maria Ida / Ozdemir, Zeynep / de Portu, Simona / Cohen, Ohad et al. | 2021
- 891
-
In Reply to Xue W, Ribalov R, Zhou Z-Y, et al. Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103–113Serbin, Michael / Yonan, Charles / Ganz, Michael L. et al. | 2021
- 893
-
Reassessing the cost-effectiveness of nivolumab for the treatment of renal cell carcinoma based on mature survival data, updated safety and lower comparator priceKim, Hansoo / Goodall, Stephen / Liew, Danny et al. | 2021
- 900
-
Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and SpainVo, Pamela / Swallow, Elyse / Wu, Eric / Zichlin, Miriam L. / Katcher, Noah / Maier-Peuschel, Monika / Naclerio, Mariantonietta / Ritrovato, Daniela / Tiwari, Santosh / Joshi, Parth et al. | 2021
- 908
-
Continuing trends in U.S. brand-name and generic drug competitionGrabowski, Henry / Long, Genia / Mortimer, Richard / Bilginsoy, Mehmet et al. | 2021
- 918
-
Quantifying spillover benefits in value assessment: a case study of increased graft survival on the US kidney transplant waitlistDennen, Syvart / Díaz Espinosa, Oliver / Birch, Kelly / Cai, Jennifer / Sung, Jennifer C. / Machado, Paula G. P. / Shafrin, Jason et al. | 2021
- 930
-
Health care resource utilization and treatment variability in the care of patients with advanced or metastatic colorectal or gastric cancerHess, Lisa M. / Zhu, Yajun Emily / Fang, Yun / Liepa, Astra M. et al. | 2021
- 939
-
Comparative economic outcomes in patients with focal seizures initiating eslicarbazepine acetate versus brivaracetam as their first adjunctive ASDMehta, Darshan / Davis, Matthew / Epstein, Andrew J. / Wensel, Brian / Grinnell, Todd / Thach, Andrew / Williams, G. Rhys et al. | 2021
- 949
-
Comparative efficacy, safety, and cost-effectiveness of abobotulinumtoxinA and onabotulinumtoxinA in children with upper limb spasticity: a systematic literature review, indirect treatment comparison, and economic evaluationDanchenko, N. / Johnston, K. M. / Haeussler, K. / Whalen, J. et al. | 2021
- 962
-
Economic burden of congenital athymia in the United States for patients receiving supportive care during the first 3 years of lifeCollins, Cathleen / Kim-Chang, Julie J. / Hsieh, Elena / Silber, Abigail / O’Hara, Matthew / Kulke, Sarah / Cooper, Megan A. et al. | 2021
- 972
-
Payer budget impact of an artificial intelligence in vitro diagnostic to modify diabetic kidney disease progressionDatar, Manasi / Burchenal, William / Donovan, Michael J. / Coca, Steven G. / Wang, Elaine / Goss, Thomas F. et al. | 2021
- 983
-
The burden of skeletal-related events in four Latin American countries: Argentina, Brazil, Colombia, and MexicoGarcia Perlaza, Javier / Aziziyeh, Rima / Zhou, Anna / De Sousa Barbosa, Vitor / Amaya, Jenny / Caporale, Joaquin / Alva, Monica Elena / Forero, Juan / Tanaka, Straus / Suri, Gaurav et al. | 2021
- 993
-
Impact of liposomal bupivacaine and provider choice on opioid use and service outcomes in Medicare outpatient surgical patientsDobson, Allen / Hartzman, Alex / Surfield, Christopher / DaVanzo, Joan E. et al. | 2021
- 1002
-
Cost of microvascular complications in people with diabetes from a public healthcare perspective: a retrospective database study in BrazilJulian, Guilherme Silva / Accetturi Pititto, Lilian Mariana / Miresashvili, Nino / Broe Honoré, Julie / Lopes Assis Coelho, Raquel Cristina / Campos, Daniel et al. | 2021
- 1011
-
Cost, healthcare utilization, and outcomes of antibody-mediated rejection in kidney transplant recipients in the USHart, Allyson / Zaun, David / Itzler, Robbin / Schladt, David / Israni, Ajay / Kasiske, Bertram et al. | 2021
- 1018
-
Economic implications of the modern treatment paradigm of glioblastoma: an analysis of global cost estimates and their utility for cost assessmentGoel, Nicholas J. / Bird, Cylaina E. / Hicks, William H. / Abdullah, Kalil G. et al. | 2021
- 1025
-
Healthcare utilization and expenditures associated with hyperkalemia management: a retrospective study of Medicare Advantage patientsDesai, Nihar R. / Alvarez, Paula J. / Golestaneh, Ladan / Woods, Steven D. / Coca, Steven G. / Rowan, Christopher G. et al. | 2021
- 1037
-
An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in EnglandRaspin, Christopher / Shankar, Rohit / Barion, Francesca / Pollit, Vicki / Murphy, Joanna / Sawyer, Laura / Danielson, Vanessa et al. | 2021
- 1052
-
Cost of hemophilia A in Turkey: an economic disease burden analysisMalhan, Simten / Öksüz, Ergün / Antmen, Bülent / Ar, Muhlis Cem / Balkan, Can / Kavaklı, Kaan et al. | 2021
- 1060
-
Economic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysisPadula, William V. / Malaviya, Shreena / Reid, Natalie M. / Cohen, Benjamin G. / Chingcuanco, Francine / Ballreich, Jeromie / Tierce, Jonothan / Alexander, G. Caleb et al. | 2021
- 1070
-
The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF modelSussman, Matthew / Di Fusco, Manuela / Tao, Charles Y. / Guo, Jennifer D. / Gillespie, John A. / Ferri, Mauricio / Adair, Nicholas / Cato, Matthew S. / Shirkhorshidian, Ilnaz / Barnes, Geoffrey D. et al. | 2021
- 1083
-
Comprehensive value assessments for new pediatric pneumococcal conjugate vaccinesHu, Tianyan / Weiss, Thomas / Bencina, Goran / Owusu-Edusei, Kwame / Petigara, Tanaz et al. | 2021
- 1087
-
Real-life management of neovascular age-related macular degeneration (nAMD) in France: a nationwide observational study using retrospective claims dataKorobelnik, Jean-François / Delcourt, Cécile / Creuzot-Garcher, Catherine / Melaine, Asma / Chassetuillier, Jules / Lejeune, Anne / Bénard, Stève / Dupont-Benjamin, Laure et al. | 2021
- 1098
-
Health and economic burden of invasive pneumococcal disease associated with 15-valent pneumococcal conjugate vaccine serotypes in children across eight European countriesHu, Tianyan / Weiss, Thomas / Bencina, Goran / Owusu-Edusei, Kwame / Petigara, Tanaz et al. | 2021
- 1109
-
Determinants of market prices for drugs under Japan’s national health insuranceMamiya, Hiroaki / Igarashi, Ataru et al. | 2021
- 1115
-
Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United StatesJain, Sneha S. / Li, Sophia S. / Xie, Jipan / Sutton, Megan B. / Fine, Jennifer T. / Edelberg, Jay M. / Gao, Wei / Spertus, John A. / Cohen, David J. et al. | 2021
- 1124
-
Cost-effectiveness of nivolumab monotherapy in the third-line treatment of small cell lung cancerSmare, Caitlin / Dave, Kiran / Juarez-Garcia, Ariadna / Abraham, Pranav / Penrod, John R. / Camidge, D. Ross / Yuan, Yong et al. | 2021
- 1134
-
Modeling the optimal sequence of biologic therapies in plaque psoriasis in SpainEgeberg, Alexander / Danø, Anne / Pedersen, Mikkel H. / Sohrt, Anne / Borg, Emma / Notario, Jaime et al. | 2021
- 1143
-
Variation in access to hemophilia A treatments in the United StatesMargaretos, Nikoletta M. / Patel, Anisha M. / Panzer, Ari D. / Lai, Rachel C. / Whiteley, Jennifer / Chambers, James D. et al. | 2021
- 1149
-
Budget impact of optimizing rifaximin-α use for the prevention of recurrent hepatic encephalopathy in The Netherlandsde Jong, Lisa Aniek / van Schoonhoven, Alexander Victor / Hofstra, Hinko Stephan / Postma, Maarten Jacobus / van Hoek, Bart et al. | 2021
- 1164
-
Cost-minimization analysis of biweekly dosing of cetuximab and FOLFIRI compared with panitumumab and FOLFOX for first-line treatment of patients with KRAS wild-type metastatic colorectal cancer in the United StatesGathirua-Mwangi, Wambui Grace / Sethi, Harsheen / Afable, Manuel Geroy / Bhattacharyya, Devarshi / Khan, Taha et al. | 2021
- 1173
-
Patient out-of-pocket costs for suspicious pulmonary nodule biopsy in lung cancer patientsZheng, Feibi / Lavin, James / Sprafka, J. Michael et al. | 2021
- 1178
-
Cost analysis of the impact of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura from a US hospital perspectivePollissard, Laurence / Leinwand, Brian I. / Fournier, Marie / Pham, Huy P. et al. | 2021
- 1185
-
Number needed to treat analysis applied to pembrolizumab plus chemotherapy for first-line treatment of non-squamous non-small cell lung cancerPaladini, Luciano / da Veiga, Cássia Rita Pereira / Cerqueira, Érica / Chabrol Haas, Laura / Datz Abadi, Márcia / Baldotto, Clarissa Seródio et al. | 2021
- 1194
-
Economic burden to commercial payers of young adults with schizophrenia in ColoradoPesa, Jacqueline / Patel, Charmi / Rotter, David / Papademetriou, Eros / Potluri, Ravi / Benson, Carmela et al. | 2021
- 1204
-
Retrospective analysis of adherence to HIV treatment and healthcare utilization in a commercially insured populationPriest, Julie / Bhak, Rachel H. / Dersarkissian, Maral / Oglesby, Alan / Kunzweiler, Colin / Fuqua, Ellie / Park, Suna / Duh, Mei Sheng / Garris, Cindy et al. | 2021
- 1212
-
Hospitalization risk in pediatric patients with bipolar disorder treated with lurasidone vs. other oral atypical antipsychotics: a real-world retrospective claims database studyKadakia, Aditi / Dembek, Carole / Liu, Yi / Dieyi, Christopher / Williams, G. Rhys et al. | 2021
- 1221
-
Phase-specific and lifetime economic burden of cervical cancer and endometrial cancer in a commercially insured United States populationShah, Ruchit / Corman, Shelby / Shah, Anuj / Kebede, Nehemiah / Nwankwo, Chizoba et al. | 2021
- 1231
-
Clinical implications and cost-effectiveness analysis of rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the NetherlandsSpoorendonk, J. A. / Briere, J.-B. / Bowrin, K. / Millier, A. / Coppens, M. / Tempelaar, S. / Verheggen, B. et al. | 2021
- 1240
-
Estimating hospital inpatient cost-savings with sucroferric oxyhydroxide in patients on chronic hemodialysis in five European countries: a cost analysisHerrero, Jose Antonio / Salomone, Mario / Ramirez de Arellano, Antonio / Schaufler, Thilo / Walpen, Sebastian et al. | 2021
- 1248
-
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2Di Fusco, Manuela / Moran, Mary M. / Cane, Alejandro / Curcio, Daniel / Khan, Farid / Malhotra, Deepa / Surinach, Andy / Miles, Amanda / Swerdlow, David / McLaughlin, John M. et al. | 2021
- 1261
-
Cost-effectiveness of high dose versus adjuvanted trivalent influenza vaccines in England and WalesMattock, Richard / Gibbons, Ilana / Moss, Joe / Mealing, Stuart / Largeron, Nathalie / Carroll, Stuart / Alvarez, Fabián P. et al. | 2021
- 1272
-
Identifying chronic disease patients using predictive algorithms in pharmacy administrative claims: an application in rheumatoid arthritisMaksabedian Hernandez, Ervant J. / Tingzon, Isabelle / Ampil, Lorenzo / Tiu, Jessica et al. | 2021
- 1280
-
Evaluating the burden of pruritus due to atopic dermatitis in Japan by patient-reported outcomesMurota, Hiroyuki / Koike, Yuta / Ishii, Kanako / Calimlim, Brian M. / Ludwikowska, Maja / Toumi, Mondher / Kawaguchi, Isao et al. | 2021
- 1290
-
Respiratory morbidity, healthcare resource use, and cost burden associated with extremely preterm birth in The NetherlandsHouben, Eline / Siffel, Csaba / Overbeek, Jetty / Penning-van Beest, Fernie / Niklas, Victoria / Sarda, Sujata P. et al. | 2021
- 1299
-
Health care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapyPilon, Dominic / Karkare, Swapna / Zhdanava, Maryia / Sheehan, John J. / Côté-Sergent, Aurélie / Shah, Aditi / Lopena, Oliver J. / Lefebvre, Patrick / Joshi, Kruti / Citrome, Leslie et al. | 2021
- 1309
-
Budget impact analysis of the DiviTum TKa assay in postmenopausal women with hormone receptor positive metastatic breast cancerCarlson, Josh J. / Guzauskas, Gregory F. / Dann, Robert A. / Ramsey, Scott D. et al. | 2021
- 1318
-
Hospitalization costs with degludec versus glargine U100 for patients with type 2 diabetes at high cardiovascular risk: Canadian costs applied to SAEs from a randomized outcomes trialTarride, Jean-Eric / Husain, Mansoor / Andersen, Andreas / Gundgaard, Jens / Luckevich, Maria / Mark, Thomas / Wagner, Lily / Pieber, Thomas R. et al. | 2021
- 1327
-
Healthcare utilization and cost burden of Huntington’s disease among Medicare beneficiaries in the United StatesExuzides, Alex / Reddy, Sheila R. / Chang, Eunice / Ta, Jamie T. / Patel, Anisha M. / Paydar, Caleb / Yohrling, George J. et al. | 2021
- 1337
-
Costs of treatment change following first-line somatostatin analog monotherapy among patients with neuroendocrine tumorsTawfik, Bernard / Ray, David / Moynihan, Meghan / Princic, Nicole et al. | 2021